Skip to main navigation Skip to search Skip to main content

Retraction Note: BET inhibitor I-BET151 sensitizes GBM cells to temozolomide via PUMA induction

  • Zhicheng Yao
  • , Shida Yang
  • , Hongyou Zhao
  • , Huike Yang
  • , Xin Jiang*
  • *Corresponding author for this work
  • The People’s Hospital of Liaoning Province
  • Louisiana State University Health Sciences Center
  • Harbin Medical University

Research output: Contribution to journalComment/debate

Original languageEnglish
Pages (from-to)1528
Number of pages1
JournalCancer Gene Therapy
Volume29
Issue number10
DOIs
Publication statusPublished - Oct 2022
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Cite this